TABLE 1 North America Cancer Gene Therapy Market, 2018 - 2021, USD Million
TABLE 2 North America Cancer Gene Therapy Market, 2022 - 2028, USD Million
TABLE 3 North America Cancer Gene Therapy Market by Therapy, 2018 - 2021, USD Million
TABLE 4 North America Cancer Gene Therapy Market by Therapy, 2022 - 2028, USD Million
TABLE 5 North America Gene Induced Immunotherapy Market by Country, 2018 - 2021, USD Million
TABLE 6 North America Gene Induced Immunotherapy Market by Country, 2022 - 2028, USD Million
TABLE 7 North America Oncolytic Virotherapy Market by Country, 2018 - 2021, USD Million
TABLE 8 North America Oncolytic Virotherapy Market by Country, 2022 - 2028, USD Million
TABLE 9 North America Gene Transfer Market by Country, 2018 - 2021, USD Million
TABLE 10 North America Gene Transfer Market by Country, 2022 - 2028, USD Million
TABLE 11 North America Cancer Gene Therapy Market by End User, 2018 - 2021, USD Million
TABLE 12 North America Cancer Gene Therapy Market by End User, 2022 - 2028, USD Million
TABLE 13 North America Hospitals Market by Country, 2018 - 2021, USD Million
TABLE 14 North America Hospitals Market by Country, 2022 - 2028, USD Million
TABLE 15 North America Diagnostic centers Market by Country, 2018 - 2021, USD Million
TABLE 16 North America Diagnostic centers Market by Country, 2022 - 2028, USD Million
TABLE 17 North America Research Institutes Market by Country, 2018 - 2021, USD Million
TABLE 18 North America Research Institutes Market by Country, 2022 - 2028, USD Million
TABLE 19 North America Cancer Gene Therapy Market by Country, 2018 - 2021, USD Million
TABLE 20 North America Cancer Gene Therapy Market by Country, 2022 - 2028, USD Million
TABLE 21 US Cancer Gene Therapy Market, 2018 - 2021, USD Million
TABLE 22 US Cancer Gene Therapy Market, 2022 - 2028, USD Million
TABLE 23 US Cancer Gene Therapy Market by Therapy, 2018 - 2021, USD Million
TABLE 24 US Cancer Gene Therapy Market by Therapy, 2022 - 2028, USD Million
TABLE 25 US Cancer Gene Therapy Market by End User, 2018 - 2021, USD Million
TABLE 26 US Cancer Gene Therapy Market by End User, 2022 - 2028, USD Million
TABLE 27 Canada Cancer Gene Therapy Market, 2018 - 2021, USD Million
TABLE 28 Canada Cancer Gene Therapy Market, 2022 - 2028, USD Million
TABLE 29 Canada Cancer Gene Therapy Market by Therapy, 2018 - 2021, USD Million
TABLE 30 Canada Cancer Gene Therapy Market by Therapy, 2022 - 2028, USD Million
TABLE 31 Canada Cancer Gene Therapy Market by End User, 2018 - 2021, USD Million
TABLE 32 Canada Cancer Gene Therapy Market by End User, 2022 - 2028, USD Million
TABLE 33 Mexico Cancer Gene Therapy Market, 2018 - 2021, USD Million
TABLE 34 Mexico Cancer Gene Therapy Market, 2022 - 2028, USD Million
TABLE 35 Mexico Cancer Gene Therapy Market by Therapy, 2018 - 2021, USD Million
TABLE 36 Mexico Cancer Gene Therapy Market by Therapy, 2022 - 2028, USD Million
TABLE 37 Mexico Cancer Gene Therapy Market by End User, 2018 - 2021, USD Million
TABLE 38 Mexico Cancer Gene Therapy Market by End User, 2022 - 2028, USD Million
TABLE 39 Rest of North America Cancer Gene Therapy Market, 2018 - 2021, USD Million
TABLE 40 Rest of North America Cancer Gene Therapy Market, 2022 - 2028, USD Million
TABLE 41 Rest of North America Cancer Gene Therapy Market by Therapy, 2018 - 2021, USD Million
TABLE 42 Rest of North America Cancer Gene Therapy Market by Therapy, 2022 - 2028, USD Million
TABLE 43 Rest of North America Cancer Gene Therapy Market by End User, 2018 - 2021, USD Million
TABLE 44 Rest of North America Cancer Gene Therapy Market by End User, 2022 - 2028, USD Million
TABLE 45 Key Information – Novartis AG
TABLE 46 Key Information – GlaxoSmithKline PLC (GSK)
TABLE 47 Key Information – Amgen, Inc.
TABLE 48 Key Information – Bristol Myers Squibb Company
TABLE 49 key Information – Karyopharm Therapeutics, Inc.
TABLE 50 Key Information – Gilead Sciences, Inc.
TABLE 51 Key information – Adaptimmune Limited
TABLE 52 Key Information – Genelux Corporation
TABLE 53 key information – Sarepta Therapeutics, Inc.
List of Figures
FIG 1 Methodology for the research
FIG 2 Recent strategies and developments: Novartis AG
FIG 3 Recent strategies and developments: Bristol Myers Squibb Company
Unique Offerings 